n-methyl-3,4-methylenedioxyamphetamine has been researched along with Catatonia in 3 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
Catatonia: A neuropsychiatric disorder characterized by one or more of the following essential features: immobility, mutism, negativism (active or passive refusal to follow commands), mannerisms, stereotypies, posturing, grimacing, excitement, echolalia, echopraxia, muscular rigidity, and stupor; sometimes punctuated by sudden violent outbursts, panic, or hallucinations. This condition may be associated with psychiatric illnesses (e.g., SCHIZOPHRENIA; MOOD DISORDERS) or organic disorders (NEUROLEPTIC MALIGNANT SYNDROME; ENCEPHALITIS, etc.). (From DSM-IV, 4th ed, 1994; APA, Thesaurus of Psychological Index Terms, 1994)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Masi, G | 1 |
Mucci, M | 1 |
Floriani, C | 1 |
Maxwell, DL | 1 |
Polkey, MI | 1 |
Henry, JA | 1 |
Lee, JW | 1 |
3 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Catatonia
Article | Year |
---|---|
Acute catatonia after a single dose of ecstasy.
Topics: Acute Disease; Adolescent; Catatonia; Clozapine; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamin | 2002 |
Hyponatraemia and catatonic stupor after taking "ecstasy".
Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Catatonia; Designer Drugs; Female; Humans; Hyponatremia; | 1993 |
Catatonic stupor after "ecstasy".
Topics: 3,4-Methylenedioxyamphetamine; Catatonia; Designer Drugs; Female; Humans; N-Methyl-3,4-methylenediox | 1994 |